Gerald P. McDole
Director/Board Member bei PALADIN LABS INC.
Vermögen: 41 069 $ am 31.03.2024
Profil
Gerald P.
McDole's current jobs include being an Independent Director at Paladin Labs, Inc., a Director at the Canadian Genetic Disease Network, a Director at the Innovation Institute of Ontario, and a Member of the Canadian Healthcare Marketing Hall of Fame.
His former jobs include being the President & Chief Executive Officer at AstraZeneca Canada, Inc. from 1999 to 2003, the President & Chief Executive Officer at Astra Pharmaceuticals, Inc. from 1985 to 2003, the President & Chief Executive Officer at Astra Pharma, Inc., the Chairman of Cipher Pharmaceuticals, Inc. from 2014 to 2016, the Chairman of STI Technologies Ltd., and the Chairman of the Advanced Coronary Treatment Foundation.
He also served as an Independent Director at Medicure, Inc. from 2004 to 2023, a Director at NeuroMedix, Inc., a Director at the Institute of Health Economics, a Director at the Canadian Stroke Network, and the President of the Canadian Foundation for Pharmacy.
Mr. McDole's education includes an MBA from Simon Fraser University and an undergraduate degree from the University of Manitoba.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MEDICURE INC.
0,47% | 31.12.2022 | 48 950 ( 0,47% ) | 41 069 $ | 31.03.2024 |
Aktive Positionen von Gerald P. McDole
Unternehmen | Position | Beginn |
---|---|---|
PALADIN LABS INC. | Director/Board Member | 01.01.2004 |
Canadian Healthcare Marketing Hall of Fame | Corporate Officer/Principal | 15.09.2010 |
Innovation Institute of Ontario | Director/Board Member | - |
Canadian Genetic Disease Network | Director/Board Member | - |
Ehemalige bekannte Positionen von Gerald P. McDole
Unternehmen | Position | Ende |
---|---|---|
MEDICURE INC. | Director/Board Member | 31.01.2023 |
CIPHER PHARMACEUTICALS INC. | Chairman | 09.08.2016 |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Director/Board Member | 20.03.2007 |
Astra Pharmaceuticals, Inc. | Chief Executive Officer | 01.10.2003 |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Chief Executive Officer | 01.01.2003 |
Ausbildung von Gerald P. McDole
Simon Fraser University | Masters Business Admin |
University of Manitoba | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MEDICURE INC. | Health Technology |
CIPHER PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 13 |
---|---|
Paladin Labs, Inc.
Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
Canadian Genetic Disease Network | |
Innovation Institute of Ontario | |
Astra Pharmaceuticals, Inc. | |
Institute of Health Economics | |
Sti Technologies Ltd.
Sti Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services STI Technologies Ltd. provides marketing solutions to the health care industry. The firm's SmartTechnology platform allows stakeholders-manufacturers, pharmacies, prescribers, and payers to optimize their patient relationships. It offers solutions for pre-launch planning, brand adoption, market uptake, revenue optimization, retention and adherence, and loss of exclusivity. The company was founded by William B. Adams and Gregory Patey in 2001 and is headquartered in Halifax, Canada. | Commercial Services |
Advanced Coronary Treatment Foundation | |
Canadian Stroke Network
Canadian Stroke Network Miscellaneous Commercial ServicesCommercial Services Canadian Stroke Network operates as a non-profit healthcare organization. The company was founded in 1999 and is headquartered in Ottawa, Canada. | Commercial Services |
Canadian Foundation for Pharmacy | |
Canadian Healthcare Marketing Hall of Fame | |
Astra Pharma, Inc. |